102 related articles for article (PubMed ID: 1871774)
1. Comparison of three physiologically based pharmacokinetic models of benzene disposition.
Bois FY; Woodruff TJ; Spear RC
Toxicol Appl Pharmacol; 1991 Aug; 110(1):79-88. PubMed ID: 1871774
[TBL] [Abstract][Full Text] [Related]
2. Modeling benzene pharmacokinetics across three sets of animal data: parametric sensitivity and risk implications.
Spear RC; Bois FY; Woodruff T; Auslander D; Parker J; Selvin S
Risk Anal; 1991 Dec; 11(4):641-54. PubMed ID: 1780503
[TBL] [Abstract][Full Text] [Related]
3. Structure and parameterization of pharmacokinetic models: their impact on model predictions.
Woodruff TJ; Bois FY; Auslander D; Spear RC
Risk Anal; 1992 Jun; 12(2):189-201. PubMed ID: 1502372
[TBL] [Abstract][Full Text] [Related]
4. Interspecies extrapolation of physiological pharmacokinetic parameter distributions.
Watanabe KH; Bois FY
Risk Anal; 1996 Dec; 16(6):741-54. PubMed ID: 8972106
[TBL] [Abstract][Full Text] [Related]
5. An analysis of exposure rate effects for benzene using a physiologically based pharmacokinetic model.
Bois FY; Paxman DG
Regul Toxicol Pharmacol; 1992 Apr; 15(2 Pt 1):122-36. PubMed ID: 1626064
[TBL] [Abstract][Full Text] [Related]
6. Optimization issues in physiological toxicokinetic modeling: a case study with benzene.
Woodruff TJ; Bois FY
Toxicol Lett; 1993 Aug; 69(2):181-96. PubMed ID: 8212060
[TBL] [Abstract][Full Text] [Related]
7. Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results.
Spear RC; Bois FY
Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):61-6. PubMed ID: 7737043
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of benzene carcinogenesis: application of a physiological model of benzene pharmacokinetics and metabolism.
Bois FY; Smith MT; Spear RC
Toxicol Lett; 1991 May; 56(3):283-98. PubMed ID: 2035176
[TBL] [Abstract][Full Text] [Related]
9. Incorporating Monte Carlo simulation into physiologically based pharmacokinetic models using advanced continuous simulation language (ACSL): a computational method.
Thomas RS; Lytle WE; Keefe TJ; Constan AA; Yang RS
Fundam Appl Toxicol; 1996 May; 31(1):19-28. PubMed ID: 8998950
[TBL] [Abstract][Full Text] [Related]
10. Co-exposure to gasoline vapor decreases benzene metabolism in Fischer-344 rats.
Travis CC; Fox MT; Simmons WM; Lyon BF
Toxicol Lett; 1992 Sep; 62(2-3):231-40. PubMed ID: 1412508
[TBL] [Abstract][Full Text] [Related]
11. In vivo metabolic interactions of benzene and toluene.
Purcell KJ; Cason GH; Gargas ML; Andersen ME; Travis CC
Toxicol Lett; 1990 Jul; 52(2):141-52. PubMed ID: 2377998
[TBL] [Abstract][Full Text] [Related]
12. Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach.
Yokley K; Tran HT; Pekari K; Rappaport S; Riihimaki V; Rothman N; Waidyanatha S; Schlosser PM
Risk Anal; 2006 Aug; 26(4):925-43. PubMed ID: 16948686
[TBL] [Abstract][Full Text] [Related]
13. Reassessing benzene risks using internal doses and Monte-Carlo uncertainty analysis.
Cox LA
Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1413-29. PubMed ID: 9118928
[TBL] [Abstract][Full Text] [Related]
14. Uncertainty, variability, and sensitivity analysis in physiological pharmacokinetic models.
Krewski D; Wang Y; Bartlett S; Krishnan K
J Biopharm Stat; 1995 Nov; 5(3):245-71. PubMed ID: 8580927
[TBL] [Abstract][Full Text] [Related]
15. Bayesian evaluation of a physiologically-based pharmacokinetic (PBPK) model of long-term kinetics of metal nanoparticles in rats.
Sweeney LM; MacCalman L; Haber LT; Kuempel ED; Tran CL
Regul Toxicol Pharmacol; 2015 Oct; 73(1):151-63. PubMed ID: 26145831
[TBL] [Abstract][Full Text] [Related]
16. Population toxicokinetics of benzene.
Bois FY; Jackson ET; Pekari K; Smith MT
Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1405-11. PubMed ID: 9118927
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of benzene.
Travis CC; Quillen JL; Arms AD
Toxicol Appl Pharmacol; 1990 Mar; 102(3):400-20. PubMed ID: 2315912
[TBL] [Abstract][Full Text] [Related]
18. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
[TBL] [Abstract][Full Text] [Related]
19. Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodies.
Glassman PM; Balthasar JP
J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):427-46. PubMed ID: 27377311
[TBL] [Abstract][Full Text] [Related]
20. Model parameter estimation and analysis: understanding parametric structure.
Li H; Watanabe K; Auslander D; Spear RC
Ann Biomed Eng; 1994; 22(1):97-111. PubMed ID: 8060031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
